SCHEMBL4861618

SCHEMBL4861618

CSc1ccc(C(=N)Nc2ccc(C(C)C)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.43
MAPT P10636 2/20 0.43
MEN1 O00255 2/20 0.43
ALDH1A1 P00352 2/20 0.43
HPGD P15428 2/20 0.43
KMT2A Q03164 2/20 0.43
GAA P10253 1/20 0.43
IDO1 P14902 1/20 0.42
LMNA P02545 3/20 0.42
KIF11 P52732 1/20 0.41
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
FPR2 P25090 1/20 0.40
MMP2 P08253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4864119 0.85 MEN1 (0.49) MAPTMEN1ALDH1A1KMT2AIDO1
SCHEMBL4856115 0.85 MEN1 (0.49) MAPTMEN1ALDH1A1KMT2AIDO1
SCHEMBL4853065 0.83 NPC1 (0.47) MAPTMEN1ALDH1A1KMT2AIDO1
SCHEMBL14193769 0.83 NPC1 (0.47) MAPTMEN1ALDH1A1KMT2AIDO1
SCHEMBL4852963 0.82 IDO1 (0.44) KDM4EMAPTMEN1ALDH1A1HPGD
SCHEMBL4857030 0.82 ALDH1A1 (0.46) MAPTMEN1ALDH1A1KMT2AIDO1
SCHEMBL4854757 0.82 ALDH1A1 (0.46) MAPTMEN1ALDH1A1KMT2AIDO1
SCHEMBL4857004 0.81 MAPT (0.49) KDM4EMAPTMEN1ALDH1A1KMT2A
SCHEMBL28144741 0.80 RAB9A (0.50) KDM4EMAPTMEN1ALDH1A1HPGD
SCHEMBL4861878 0.79 RAB9A (0.50) KDM4EMAPTMEN1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365069-B2 Pyrimidone derivatives BEXEL PHARMACEUTICALS INC. (US) 2008-04-29 US disclosed
US-7365069-B2 Pyrimidone derivatives BEXEL PHARMACEUTICALS INC. (US) 2008-04-29 US disclosed
US-7365069-B2 Pyrimidone derivatives BEXEL PHARMACEUTICALS INC. (US) 2008-04-29 US disclosed
US-20040259891-A1 Novel pyrimidon derivatives ORCHID CHEMICAL & PHARMACEUTICALS LIMITED (IN) 2004-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259891-A1 Novel pyrimidon derivatives TYMS, TPMT, TYMP KDM4E 4161/4885MAPT 28/4885MEN1 917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.